What the GMC actually requires for your annual appraisal: the six types of supporting information, cycle deadlines for PSQ, MSF and QI, plus a pre-appraisal checklist.
What the GMC actually requires for your annual appraisal: the six types of supporting information, cycle deadlines for PSQ, MSF and QI, plus a pre-appraisal checklist.
A cultural obsession met a miracle drug met a monopoly price: the bill landed in a health service that had no plan to pay it. A tongue-in-cheek autopsy of the most expensive medicine in NHS history. It is easier to be furious at a person than at a spreadsheet. So when the health service quietly […]
Quick answer: QOF 2026/27 introduces six new or significantly changed indicators that Practice Managers must prepare for now. DM037 requires all 8 NICE diabetes care processes per patient, HF009 mandates 4-pillar heart failure therapy, OB004 and OB005 replace the Weight Management Enhanced Service with 18 new obesity points, and CD001/CD002 consolidate cardiovascular blood pressure control […]
Heart disease remains the leading cause of death globally. Despite advancements in understanding risk factors like high cholesterol and blood pressure, a groundbreaking discovery from Spanish researchers at the National Center for Cardiovascular Research (CNIC) in Madrid has unveiled an unexpected villain: your gut bacteria. Fifteen years ago, researchers set out to study thousands of […]
CHOL001 and CHOL002 are no longer in the Quality and Outcomes Framework. From April 2024 they were replaced by CHOL003 and CHOL004, and for 2025/26 these two indicators became some of the highest-point earners in the entire QOF. Between them they now carry 82 points, more than any other clinical area in the framework. This […]
A Fresh Look at an Old Ally: Mirtazapine for Insomnia in the Older Adult (7.5mg superior than 15mg) https://doi.org/10.1093/ageing/afaf050 1. Why This Conversation Won’t Go Away Anyone running a geriatric clinic knows the nightly battle cry: “Doctor, I just can’t sleep.” Benzodiazepines and so-called “Z-drugs” remain common fixes, yet both families bring cognitive haze, falls, […]
The Competition and Markets Authority (CMA) has called for an indepth inquiry into the EMIS Health PLC acquistion by United Health Group (UNH) Inc. The reasons cited are: The combined market share of UNH and EMIS in the supply of healthcare IT systems to GPs in the UK. The potential for the merger to lead […]
A common characteristic of neurodegenerative diseases such as Huntington’s disease and various forms of dementia is the build-up in the brain of clusters—known as aggregates—of misfolded proteins, such as huntingtin and tau. These aggregates lead to the degradation and eventual death of brain cells and the onset of symptoms. One method that our bodies use […]
Challenges of Treating Chronic Pain Chronic pain is a complex and difficult condition to treat despite the progress in neuroscience research over the last two decades. A recent overview by Ferreira and colleagues has added to the growing body of evidence on the use of medicines for pain, highlighting the limitations of current medical treatments. […]
Introduction Sickle cell disease is a genetic disorder that affects the hemoglobin in red blood cells. It is caused by a single point mutation in the gene encoding β-globin (HBB), leading to the production of sickle hemoglobin and impaired red-cell function. Patients with sickle cell disease often have vaso-occlusive events, progressive vasculopathy, and chronic hemolytic […]